Trial intelligence / Profile preview

External ointment therapy for mammary gland hyperplasia

ChiCTR-TRC-12002920Phase 4Completed

Sponsor
Third Affiliated Hospital, Beijing University of Chinese Medicine
Start
May 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Sanjie Rupi Gao in breast hyperplasia (2 arms), sponsored by Third Affiliated Hospital, Beijing University of Chinese Medicine. Primary endpoints: Breast pain, Breast tumor size and 2 more. Started May 2010; status: completed.

02

Drugs

Sanjie Rupi Gao
03

Conditions

breast hyperplasia

Beyond the preview

Go deeper on ChiCTR-TRC-12002920.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002920.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call